<code id='95E5E9774B'></code><style id='95E5E9774B'></style>
    • <acronym id='95E5E9774B'></acronym>
      <center id='95E5E9774B'><center id='95E5E9774B'><tfoot id='95E5E9774B'></tfoot></center><abbr id='95E5E9774B'><dir id='95E5E9774B'><tfoot id='95E5E9774B'></tfoot><noframes id='95E5E9774B'>

    • <optgroup id='95E5E9774B'><strike id='95E5E9774B'><sup id='95E5E9774B'></sup></strike><code id='95E5E9774B'></code></optgroup>
        1. <b id='95E5E9774B'><label id='95E5E9774B'><select id='95E5E9774B'><dt id='95E5E9774B'><span id='95E5E9774B'></span></dt></select></label></b><u id='95E5E9774B'></u>
          <i id='95E5E9774B'><strike id='95E5E9774B'><tt id='95E5E9774B'><pre id='95E5E9774B'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:3
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          U.K. sequencing study surfaces new findings about tumor DNA
          U.K. sequencing study surfaces new findings about tumor DNA

          AdobeLONDON—Adecadeago,theU.K.launchedits100,000GenomesProject,amajorresearchendeavorthatinvolvedseq

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Burning questions for the 2024 JPM Healthcare Conference

          AlexHogan/STATTheJ.P.MorganHealthcareConferenceisuponus,bringingitsfreneticmeetings,crowdedhallways,